ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Lycopodium 30C HPUS

Also known as: Lycopodium 30C HPUS, Club moss, Wolf’s-foot clubmoss, Lycopodium clavatum

Overview

Lycopodium 30C HPUS is a homeopathic preparation derived from the plant Lycopodium clavatum, commonly known as club moss. The '30C' potency indicates an extreme dilution, specifically 10^-60 times, meaning no original molecules of the plant material are present. It is traditionally used in homeopathy for a range of conditions, including digestive issues, liver complaints, and urinary problems. However, these applications are based on homeopathic principles rather than conventional pharmacological evidence. Due to its ultra-diluted nature, Lycopodium 30C does not contain any measurable active ingredients, and its efficacy is a subject of ongoing scientific debate, with conventional research generally finding a low level of evidence for its clinical benefits.

Benefits

Systematic reviews and meta-analyses of homeopathic remedies, including those like Lycopodium 30C, consistently indicate no statistically significant clinical benefits beyond a placebo effect in well-designed, controlled trials. While some individual randomized controlled trials (RCTs) have reported positive effects on symptom relief for conditions such as upper respiratory infections or otorhinolaryngologic complaints, these studies are often small, heterogeneous, and carry a high risk of bias. The observed effects in such studies are typically modest, not statistically significant, or lack reproducibility. Overall, there is no high-quality evidence to support the efficacy of Lycopodium 30C for any specific clinical indication with clear effect sizes or clinical significance.

How it works

Lycopodium 30C, being an ultra-diluted homeopathic preparation, contains no pharmacologically active molecules. Consequently, there is no established conventional biochemical or physiological mechanism of action. Homeopathic theories propose mechanisms such as 'water memory' or electromagnetic resonance, suggesting that the dilution process imprints a therapeutic 'energy' or 'information' onto the water. However, these proposed mechanisms lack empirical support from rigorous scientific studies and are not recognized within conventional medicine. The concepts of absorption and bioavailability, which are central to conventional pharmacology, are not applicable to Lycopodium 30C due to the absence of any active substance.

Side effects

Lycopodium 30C is generally considered safe for consumption due to its extreme dilution, which means it contains no measurable amount of the original plant material. As a result, there are no known serious adverse effects reported in clinical trials or systematic reviews. Any mild adverse events, if experienced, are rare and typically indistinguishable from placebo effects. There are no documented drug interactions or contraindications associated with Lycopodium 30C, primarily because it lacks active pharmacological components. Its safety profile is largely attributed to its inert nature at the 30C dilution.

Dosage

In homeopathic practice, Lycopodium 30C is typically administered orally, often in the form of pellets or liquid dilutions. Dosing regimens can vary widely, with practitioners often recommending multiple doses daily. However, there are no standardized dosing guidelines based on rigorous clinical trials, nor is there a concept of a minimum effective dose or maximum safe dose in the conventional pharmacological sense, given the ultra-dilution. The timing and duration of treatment are highly individualized in homeopathic practice and are not supported by evidence-based research. Users should consult a qualified homeopathic practitioner for specific dosing recommendations, though it's important to note these are not evidence-based.

FAQs

Is Lycopodium 30C effective?

Current high-quality scientific evidence does not support the efficacy of Lycopodium 30C beyond a placebo effect for any clinical condition.

Is Lycopodium 30C safe?

Yes, it is considered safe due to its extreme dilution, which means it contains no active ingredients that could cause harm or interact with medications.

How quickly does Lycopodium 30C work?

There is no reliable scientific data on the onset of action. Any perceived effects are likely attributable to the placebo effect rather than the remedy itself.

Can Lycopodium 30C replace conventional medical treatments?

No, Lycopodium 30C should not be used as a replacement for evidence-based conventional medical treatments, especially for serious health conditions.

Research Sources

  • https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0040-1702291.pdf – This source discusses the lack of empirical support for proposed homeopathic mechanisms like 'water memory' or electromagnetic resonance in rigorous scientific studies, highlighting the absence of a conventional biochemical mechanism for ultra-diluted preparations.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC11620159/ – This systematic review by Mathie et al. (2017) found no statistically significant benefit of homeopathy, including non-individualized remedies, over placebo in well-controlled trials. It noted some individual positive outcomes but with low certainty due to heterogeneity and risk of bias.
  • https://www.hri-research.org/wp-content/uploads/2022/08/SRMA-Protocol-Non-indiv-Hom-30-10-14-2-column.pdf – This is a protocol for a meta-analysis by HRI Research, planning to assess the treatment effect of non-individualized homeopathy. It acknowledges that previous meta-analyses have shown no robust effect and emphasizes methodological rigor, with full results pending.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC1513149/ – This review by Bellavite et al. (2006) examined clinical studies on homeopathy, including 12 RCTs, for upper respiratory and ENT conditions. It reported mixed results and some symptom improvement but concluded there was no strong evidence for objective outcomes, citing small studies and methodological issues.